Trademarkia Logo

About 110 Trademarks found for “TABLET DESIGN”

Filters

Also try searching for:

TABLET DESIGN*

TABL*

*IGN

TA*GN

637455
ABANDONED

on 25 Oct 1991

WHITE TABLET DESIGN

SEARLE CANADA INC.

637455 · 31 Jul 1989

005

Pharmaceutical preparations namely tablets containing 120 mg. of verap...

637454
REFUSED

on 1 Nov 1995

YELLOW TABLET DESIGN

MONSANTO CANADA INC.

637454 · 31 Jul 1989

005

Pharmaceutical preparations namely tablets containing 80 mg. of verapa...

630536
REFUSED IN ACCORDANCE WITH TRADEMARKS OPPOSITION BOARD DECISION

on 2 Jun 2004

TABLET DESIGN (PINK)

NOVARTIS PHARMACEUTICALS CANADA INC.

630536 · 25 Apr 1989

005

Pharmaceutical preparations, namely diclofenac sodium.

630537
REFUSED IN ACCORDANCE WITH TRADEMARKS OPPOSITION BOARD DECISION

on 2 Jun 2004

TABLET DESIGN (PINK)

NOVARTIS PHARMACEUTICALS CANADA INC.

630537 · 25 Apr 1989

005

Pharmaceutical preparations, namely diclofenac sodium.

630538
ABANDONED

on 19 Jul 1996

TABLET DESIGN (BROWN)

CIBA-GEIGY CANADA LTD.

630538 · 25 Apr 1989

005

Pharmaceutical preparations, namely diclofenac sodium.

630539
ABANDONED

on 19 Jul 1996

TABLET DESIGN (YELLOW)

CIBA-GEIGY CANADA LTD.

630539 · 25 Apr 1989

005

Pharmaceutical preparations, namely diclofenac sodium.

630540
ABANDONED

on 25 Jan 1996

TABLET DESIGN (RED)

CIBA-GEIGY CANADA LTD.

630540 · 25 Apr 1989

005

Pharmaceutical preparations, namely metoprolol tartrate.

630541
ABANDONED

on 25 Jan 1996

TABLET DESIGN (BLUE)

CIBA-GEIGY CANADA LTD.

630541 · 25 Apr 1989

005

Pharmaceutical preparations, namely metoprolol tartrate.

1798792
WITHDRAWN BY OWNER

on 16 Sept 2020

7977 SOVALDI Tablet Design

Gilead Sciences Ireland UC

1798792 · 2 Sept 2016

005

Pharmaceutical preparations for the treatment of liver diseases and di...

1798793
WITHDRAWN BY OWNER

on 21 Jul 2020

7985 HARVONI Tablet Design

Gilead Sciences Ireland UC

1798793 · 2 Sept 2016

005

Pharmaceutical preparations for the treatment of liver diseases and di...

Owners

Reckitt benckiser n.V. (21)

Astrazeneca ab (11)

Pfizer canada inc. (10)

Bristol-myers squibb company (6)

Pfizer products inc. a connecticut corporation (5)

Purdue pharma (5)

Ciba-geigy canada ltd. (4)

Merck frosst canada & co./ merck frosst canada & cie. (4)

Glaxo group limited (3)

Henkel kgaa (3)

Categories

Class 5 (81)

Class 3 (30)

Class 1 (21)

Class 11 (19)

Class 21 (17)

Class 16 (6)

Class 9 (3)

Class 30 (3)

Class 25 (2)

Class 35 (2)

Class 38 (2)

Class 42 (2)

Class 2 (1)

Class 4 (1)

Class 6 (1)

Class 7 (1)

Class 8 (1)

Class 10 (1)

Class 12 (1)

Class 13 (1)

Class 14 (1)

Class 15 (1)

Class 17 (1)

Class 18 (1)

Class 19 (1)

Class 20 (1)

Class 22 (1)

Class 23 (1)

Class 24 (1)

Class 26 (1)

Class 27 (1)

Class 28 (1)

Class 29 (1)

Class 31 (1)

Class 32 (1)

Class 33 (1)

Class 34 (1)

Class 36 (1)

Class 37 (1)

Class 39 (1)

Class 40 (1)

Class 41 (1)

Class 43 (1)

Class 44 (1)

Class 45 (1)

Correspondents

Smart & biggar lp (36)

Gowling wlg (canada) llp (29)

Marks & clerk (9)

Borden ladner gervais llp (3)

Osler, hoskin & harcourt llp (3)

Cassels brock & blackwell llp (1)

Perley-robertson, hill & mcdougall llp (1)

Page 5 of 11